Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

TOBII-DYNAVOX — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

TOBII-DYNAVOX

via HART HEALTH STRATEGIES

3rd Quarter (July 1 - Sep 30) · 2024Posted Oct 10, 2024Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: TOBII-DYNAVOX
Description: medical device company
Location: Pennsylvania · United States of America

Registrant

Firm: HART HEALTH STRATEGIES
Description: Healthcare Consulting Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Monitoring Healthcare regulations and legislation
LobbyistsVICKI HART · TIMOTHY YEHL · MATTHEW DUCKWORTH · ROBERT STEPHEN JASAK jd
Covered position (VICKI HART): Senator Bob Dole; Senator Trent Lott
Covered position (TIMOTHY YEHL): Congressman Frank Pallone; Senator Frank Lautenberg
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.